VectraCor

VectraCor uses its patented technology to design and develop medical devices to simplify and reduce costs of diagnostic testing as well as improve patient care. Our latest technology, VectraplexECG can detect ECG changes suggestive of a heart attack and derive a 15-22 lead ECG utilizing only 5-electrodes. We have a entire suite of products that are durable, mobile, and ready to turn an off-the-shelf tablet or laptop into a medical device. Our products are FDA cleared, CE marked, and VectraCor is ISO-13485 certified. VectraCor’s mission is to develop and commercialize a portfolio of products that utilize its patented intellectual property, simplifying and providing a faster method for diagnosis, prevention, and treatment of cardiac, pulmonary, and neurological diseases.